激光泪道成形联合双管人工泪道置入治疗泪道狭窄  

Laser Forming Joint Dual Artificial Lacrimal Tube Placement in the Treatment of Stenosis of Lacrimal Passages

作　　者：高付林[1] 胡莲娜[1] 麻南[1] 石圆圆[1] 

机构地区：[1]解放军第306医院眼科,北京100101

出　　处：《医学综述》2013年第8期1529-1530,共2页Medical Recapitulate

摘　　要：目的探讨激光泪道成形联合双管人工泪道置入治疗泪道狭窄的疗效。方法选取2009年9月至2011年9月在解放军第306医院门诊治疗的18例泪道狭窄、泪道阻塞的患者进行眼激光泪道成形联合双管人工泪道置入治疗,观察其疗效情况。结果 18例患者术后1周内所有溢泪症状减轻或消退,无泪溢流脓,冲洗泪道通畅。随访6～24个月后,患者全部好转,治愈率为80%,没有无效和复发病例。结论泪道激光成形联合人工泪道置入可阻止泪道黏膜重新粘连、阻塞,并抑制结缔组织增生,是治疗泪道狭窄或阻塞的有效方法。Objective To investigate the effectiveness of laser forming joint dual artificial lacrimal duct placement in the treatment of stenosis of lacrimal passages. Methods 18 cases of out-patients with stenosis of lacrimal passages or blockage treated by PLA 30Ch Hospital from Sep. 2009 to Sep. 2011 were selected. All of these patients were treated by laser forming joint dual artificial lacrimal tube placement and the effec- tiveness was observed. Results The symptom of all these 18 patients was alleviated or disappeared,without suppurating. Followed up for 6 to 24 months,all the patients took a favorable turn. The cure rate was 80%. There was no ineffective or recurrent case. Conclusion Laser forming joint dual artificial lacrimal tube placement can prevent the mucosal adhesion, obstruction, and connective tissue hyperplasia, therefore is an effective method for treating stenosis of lacrimal passages and obstruction.

关 键 词：激光 双管人工泪管 泪道狭窄 

分 类 号：R779.6[医药卫生—眼科]